The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
The cases of H3N2 flu have been reported in Delhi and other NCR cities. A recent survey said that nearly 69% of households in Delhi-NCR have reported at least one member down with flu-like illness ...
The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...
A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...
Research published in the journal BMJ Open in May found that an annual blood test for cancer could lead to 49 per cent fewer ...
The approval of Medicare coverage could potentially unlock a large market segment for Lucid Diagnostics' devices. Read why LUCD stock is a Hold.
News-Medical.Net on MSN
Reimagining light scattering for biotherapeutics
Wyatt Technology's DynaPro Plate Reader 4 integrates advanced light scattering techniques, optimizing workflows in ...
MotorTrend on MSN
What Your Check-Engine Light Means, and What To Do About It!
When the dreaded malfunction indicator light turns on, it’s not the end of the world. Here’s how to cope with an MIL!
Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results